XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.3
Share-Based Payments: (Tables)
9 Months Ended
Sep. 30, 2025
Equity:  
The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2025:

The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2025:

 

    Number of Shares     Weighted Average Grant-Date Fair Value  
Nonvested options at January 1, 2025     118,650     $ 30.02  
Nonvested options granted            
Nonvested options vested or forfeited     (8,000 )   $ 23.90  
Nonvested options at September 30, 2025     110,650     $ 30.46  
The following table summarizes stock option information as of September 30, 2025:

The following table summarizes stock option information as of September 30, 2025:

 

    Shares     Weighted Average
Exercise Price
 
             
Outstanding at January 1, 2025     248,430     $ 103.00  
Options forfeited     (7,100 )     121.22  
Options exercised     (27,430 )     76.98  
                 
Outstanding at September 30, 2025     213,900     $ 105.73  
                 
Options exercisable     103,250     $ 82.55  
Options available for future grants     499,495          
Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2025 and 2024 were as follows:

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2025 and 2024 were as follows:

 

(In thousands)   September 30, 2025     September 30, 2024  
             
Cash proceeds from stock options exercised   $ 2,112     $ 1,729  
Tax benefits     205       272  
Intrinsic value of stock options exercised     1,618       1,721